US SB526 | 2025-2026 | 119th Congress
Status
Spectrum: Slight Partisan Bill (Republican 8-4)
Status: Introduced on February 11 2025 - 25% progression
Action: 2025-02-11 - Read twice and referred to the Committee on Commerce, Science, and Transportation.
Pending: Senate Commerce, Science, And Transportation Committee
Status: Introduced on February 11 2025 - 25% progression
Action: 2025-02-11 - Read twice and referred to the Committee on Commerce, Science, and Transportation.
Pending: Senate Commerce, Science, And Transportation Committee
Summary
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Title
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Sponsors
Sen. Chuck Grassley [R-IA] | Sen. Maria Cantwell [D-WA] | Sen. Joni Ernst [R-IA] | Sen. Peter Welch [D-VT] |
Sen. Shelley Capito [R-WV] | Sen. Jeanne Shaheen [D-NH] | Sen. Roger Marshall [R-KS] | Sen. Martin Heinrich [D-NM] |
Sen. Jerry Moran [R-KS] | Sen. Cindy Hyde-Smith [R-MS] | Sen. Thom Tillis [R-NC] | Sen. Mike Rounds [R-SD] |
History
Date | Chamber | Action |
---|---|---|
2025-02-11 | Senate | Read twice and referred to the Committee on Commerce, Science, and Transportation. |
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/119th-congress/senate-bill/526/all-info |